Oncology Clinical Trials Market Size, Share & Trends Analysis Report By Phase Type (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional Study, Observational Study, Expanded Access Study), By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                  1.1 Market Segmentation
                  1.2 Research Methodology
                  1.3 Information Procurement
                      1.3.1 Purchased database
                      1.3.2 GVR’s Internal Database
                      1.3.3 Secondary sources
                      1.3.4 Primary research
                  1.4 Information or Data Analysis
                      1.4.1 Data Analysis Models
                  1.5 Market Formulation & Validation
                  1.6 Model Details
                      1.6.1 Commodity flow analysis
                          1.6.1.1 Commodity Flow Analysis (Model 1)
                              1.6.1.1.1 Approach 1: Commodity Flow Approach
                  1.7 List of Secondary Sources
                  1.8 List of Abbreviations
                  1.9 Objectives
                      1.9.1 Objective 1
                      1.9.2 Objective 2
                      1.9.3 Objective 3
Chapter 2 Executive Summary
                  2.1 Market Outlook
                      2.1.1 Regional Insights
                      2.1.2 Competitive Landscape
                  2.2 Market Snapshot
                  2.3 Segment Snapshot
                  2.4 Segment Snapshot
                  2.5 Competitive Landscape
Chapter 3 Oncology Clinical Trials Market Variables and Trends
                  3.1 Market Dynamics
                      3.1.1 Market driver impact analysis
                          3.1.1.1 Increasing prevalence of Cancer
                          3.1.1.2 Rise in the number of CROs for conducting research activities
                      3.1.2 Market restraint impact analysis
                          3.1.2.1 High cost associated with oncological clinical trial
                      3.1.3 Market Opportunities impact analysis
                          3.1.3.1 Technological Advancements
                      3.1.4 Market challenges impact analysis
                          3.1.4.1 Strict regulations for patient enrollment in clinical trials
                  3.2 Industry Analysis Tools
                      3.2.1 Porter’s analysis
                      3.2.2 Macroeconomic analysis
Chapter 4 Oncology Clinical Trials Market: Phase Type Analysis
                  4.1 Type Movement Analysis & Market Share, 2022 & 2030
                  4.2 Oncology Clinical Trials Market Estimates & Forecast, By Phase (USD Million)
                  4.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the Type
                      4.3.1 Phase I
                          4.3.1.1 Phase I market, 2018 - 2030 (USD Million)
                      4.3.2 Phase II
                          4.3.2.1 Phase II market, 2018 - 2030 (USD Million)
                      4.3.3 Phase III
                          4.3.3.1 Phase III market, 2018 - 2030 (USD Million)
                      4.3.4 Phase IV
                          4.3.4.1 Phase IV market, 2018 - 2030 (USD Million)
Chapter 5 Oncology Clinical Trials Market: Study Design Analysis
                  5.1 Study Design Movement Analysis & Market Share, 2022 & 2030
                  5.2 Oncology Clinical Trials Market Estimates & Forecast, By Study Design (USD Million)
                  5.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the Study Design
                      5.3.1 Interventional
                          5.3.1.1 Interventional market, 2018 - 2030 (USD Million)
                      5.3.2 Observational
                          5.3.2.1 Observational market, 2018 - 2030 (USD Million)
                      5.3.3 Expanded access trials
                          5.3.3.1 Expanded Access market, 2018 - 2030 (USD Million)
Chapter 6 Oncology Clinical Trials Market: Regional Estimates & Trend Analysis
                  6.1 Oncology Clinical Trials Market: Regional Outlook
                  6.2 North America
                      6.2.1 North america oncology clinical trials market estimates & Forecasts, 2018 - 2030 (USD Million)
                      6.2.2 U.S.
                          6.2.2.1 Key country dynamics
                          6.2.2.2 U.S. oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.2.3 Canada
                          6.2.3.1 Key country dynamics
                          6.2.3.2 Canada oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                  6.3 Europe
                          6.3.1.1 Europe oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.3.2 UK
                          6.3.2.1 Key country dynamics
                          6.3.2.2 UK oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.3.3 Germany
                          6.3.3.1 Key country dynamics
                          6.3.3.2 Germany oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.3.4 France
                          6.3.4.1 Key country dynamics
                          6.3.4.2 France oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.3.5 Italy
                          6.3.5.1 Key country dynamics
                          6.3.5.2 Italy oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.3.6 Spain
                          6.3.6.1 Key country dynamics
                          6.3.6.2 Spain oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.3.7 Sweden
                          6.3.7.1 Key country dynamics
                          6.3.7.2 Sweden oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.3.8 Denmark
                          6.3.8.1 Key country dynamics
                          6.3.8.2 Denmark oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.3.9 NORWAY
                          6.3.9.1 Key country dynamics
                          6.3.9.2 Norway oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                  6.4 ASIA Pacific
                          6.4.1.1 Asia Pacific oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.4.2 Japan
                          6.4.2.1 Key country dynamics
                          6.4.2.2 Japan oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.4.3 China
                          6.4.3.1 Key country dynamics
                          6.4.3.2 China oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.4.4 India
                          6.4.4.1 Key country dynamics
                          6.4.4.2 India oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.4.5 Australia
                          6.4.5.1 Key country dynamics
                          6.4.5.2 Australia oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.4.6 South Korea
                          6.4.6.1 Key country dynamics
                          6.4.6.2 South Korea oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.4.7 Thailand
                          6.4.7.1 Key country dynamics
                          6.4.7.2 Thailand oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                  6.5 Latin America
                          6.5.1.1 Latin America oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.5.2 Brazil
                          6.5.2.1 Key country dynamics
                          6.5.2.2 Brazil oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.5.3 Mexico
                          6.5.3.1 Key country dynamics
                          6.5.3.2 Mexico oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.5.4 Argentina
                          6.5.4.1 Key country dynamics
                          6.5.4.2 Argentina oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                  6.6 Middle East & Africa
                          6.6.1.1 Middle East & Africa oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.6.2 South Africa
                          6.6.2.1 Key country dynamics
                          6.6.2.2 South Africa oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.6.3 Saudi Arabia
                          6.6.3.1 Key country dynamics
                          6.6.3.2 Saudi Arabia oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.6.4 UAE
                          6.6.4.1 Key country dynamics
                          6.6.4.2 UAE oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
                      6.6.5 Kuwait
                          6.6.5.1 Key country dynamics
                          6.6.5.2 Kuwait oncology clinical trials market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7 Competitive Analysis
                  7.1 Company Competitive Landscape
                  7.1 Recent Developments & Impact Analysis, By Key Market Participants
                  7.2 Market Participant Categorization
                      7.2.1 AstraZeneca
                          7.2.1.1 Company overview
                          7.2.1.2 Financial performance
                          7.2.1.3 Phase benchmarking
                          7.2.1.4 Strategic initiatives
                      7.2.2 Merck & Co., Inc
                          7.2.2.1 Company overview
                          7.2.2.2 Financial performance
                          7.2.2.3 Phase benchmarking
                          7.2.2.4 Strategic initiatives
                      7.2.3 IQVIA Inc
                          7.2.3.1 Company overview
                          7.2.3.2 Financial performance
                          7.2.3.3 Phase benchmarking
                          7.2.3.4 Strategic initiatives
                      7.2.4 Gilead Sciences, Inc
                          7.2.4.1 Company overview
                          7.2.4.2 Financial performance
                          7.2.4.3 Phase benchmarking
                          7.2.4.4 Strategic initiatives
                      7.2.5 F. Hoffmann-La Roche Ltd
                          7.2.5.1 Company overview
                          7.2.5.2 Financial performance
                          7.2.5.3 Phase benchmarking
                          7.2.5.4 Strategic initiatives
                      7.2.6 PAREXEL International Corporation
                          7.2.6.1 Company overview
                          7.2.6.2 Financial performance
                          7.2.6.3 Phase benchmarking
                          7.2.6.4 Strategic initiatives
                      7.2.7 PRA Health Sciences
                          7.2.7.1 Company overview
                          7.2.7.2 Financial performance
                          7.2.7.3 Phase benchmarking
                          7.2.7.4 Strategic initiatives
                      7.2.8 Medpace
                          7.2.8.1 Company overview
                          7.2.8.2 Financial performance
                          7.2.8.3 Phase benchmarking
                          7.2.8.4 Strategic initiatives
                      7.2.9 Pivotal
                          7.2.9.1 Company overview
                          7.2.9.2 Financial performance
                          7.2.9.3 Phase benchmarking
                          7.2.9.4 Strategic initiatives
Chapter 8 Analyst Perspective

List of Tables

Table 1 List of abbreviation
Table 2 North America oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 3 North America oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 4 North America oncology clinical trials market, by region, 2018 - 2030 (USD million)
Table 5 U.S. oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 6 U.S. oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 7 Canada oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 8 Canada oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 9 Europe oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 10 Europe oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 11 Europe oncology clinical trials market, by region, 2018 - 2030 (USD million)
Table 12 Germany oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 13 Germany oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 14 UK oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 15 UK oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 16 France oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 17 France oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 18 Italy oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 19 Italy oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 20 Spain oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 21 Spain oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 22 Sweden oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 23 Sweden oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 24 Norway oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 25 Norway oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 26 Denmark oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 27 Denmark oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 28 Asia Pacific oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 29 Asia Pacific oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 30 Asia Pacific oncology clinical trials market, by region, 2018 - 2030 (USD million)
Table 31 China oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 32 China oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 33 Japan oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 34 Japan oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 35 India oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 36 India oncology clinical trials market, by study design, 2018 - 2030 (USD Million)
Table 37 Australia oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 38 Australia oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 39 Thailand oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 40 Thailand oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 41 South Korea oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 42 South Korea oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 43 Latin America oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 44 Latin America oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 45 Latin America oncology clinical trials market, by region, 2018 - 2030 (USD million)
Table 46 Brazil oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 47 Brazil oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 48 Brazil oncology clinical trials market, by application, 2018 - 2030 (USD million)
Table 49 Mexico oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 50 Mexico oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 51 Argentina oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 52 Argentina oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 53 Middle East and Africa oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 54 Middle East and Africa oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 55 Middle East and Africa oncology clinical trials market, by region, 2018 - 2030 (USD million)
Table 56 South Africa oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 57 South Africa oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 58 Saudi Arabia oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 59 Saudi Arabia oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 60 UAE oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 61 UAE oncology clinical trials market, by study design, 2018 - 2030 (USD million)
Table 62 Kuwait oncology clinical trials market, by phase, 2018 - 2030 (USD million)
Table 63 Kuwait oncology clinical trials market, by study design, 2018 - 2030 (USD million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Oncology clinical trials: Market outlook
Fig. 9 Oncology clinical trials: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Oncology clinical trials market driver impact
Fig. 15 Oncology clinical trials market restraint impact
Fig. 16 Oncology clinical trials market strategic initiatives analysis
Fig. 17 Oncology clinical trials market: Type movement analysis
Fig. 18 Oncology clinical trials market: type outlook and key takeaways
Fig. 19 Phase I market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 20 Phase II market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 21 Phase III market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 22 Phase IV market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 23 market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 24 Oncology clinical trials market: study design movement analysis
Fig. 25 Oncology clinical trials market: study design outlook and key takeaways
Fig. 26 Interventional studies market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 27 Observational studies market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 28 Expanded access studies market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 29 Global oncology clinical trials market: Regional movement analysis
Fig. 30 Global oncology clinical trials market: Regional outlook and key takeaways
Fig. 31 North America market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 32 U.S. market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 34 Europe market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 35 UK market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 37 France market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 38 Italy market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 39 Spain market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 40 Sweden market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 41 Norway market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 42 Denmark market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 44 Japan market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 45 China market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 46 India market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 48 Thailand market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 49 South Korea market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 50 Latin America market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 51 Brazil market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 52 Mexico market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 53 Argentina market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 54 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 56 South Africa market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 57 UAE market estimates and forecasts, 2018 - 2030 (USD million)
Fig. 58 Kuwait market estimates and forecasts, 2018 - 2030 (USD million)